Nu Skin Enterprises, Inc. — Earnings Quality Grade C
NUS · Consumer Defensive
Some red flags
Screening Summary
Management Signals
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 10 days, change -1 days YoY
AR growth -22.1% vs revenue growth -14.3%
Revenue -14.3%, CFFO -28.2%. Cash follows revenue
Expense Quality
Inventory -6.1% vs COGS -17.5%. Normal
CapEx growth -17.6% vs revenue -14.3%. Normal
SG&A/Gross Profit = 91.2%, exceeds 70%
Gross margin 69.4%, change +1.2pp. Stable
Cash Flow Quality
CFFO/NI = 0.50. Below 1.0
FCF $0.0B, FCF/NI = 0.29
Accruals ratio = 5.7%. Elevated
Cash $0.2B covers 78% of debt $0.3B
Balance Sheet Health
Goodwill+Intangibles $0.1B = 16% of equity. Manageable
Debt/EBITDA = 1.2x. Healthy
Other assets -23.6% vs revenue -14.3%. Normal
No write-off data
Acquisition Risk
FCF after acquisitions positive
Goodwill+Intangibles change -20% YoY. Normal
Manipulation Score
M-Score = -2.36 (< -2.22). Unlikely manipulator
Portfolio monitoring
Monitor NUS continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25